8.4% w/v Sodium Bicarbonate Intravenous Infusion BP Ireland - English - HPRA (Health Products Regulatory Authority)

8.4% w/v sodium bicarbonate intravenous infusion bp

b. braun medical limited - sodium bicarbonate - solution for infusion - 8.4 percent weight/volume - electrolyte solutions; sodium bicarbonate

DEXMEDETOMIDINE KABI dexmedetomidine (as hydrochloride) 400 micrograms/4 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

dexmedetomidine kabi dexmedetomidine (as hydrochloride) 400 micrograms/4 ml concentrated injection vial

fresenius kabi australia pty ltd - dexmedetomidine hydrochloride, quantity: 472 microgram (equivalent: dexmedetomidine, qty 400 microgram) - injection, concentrated - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation,for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine kabi by continuous infusion in these patients should not exceed 24 hours.,procedural sedation,for sedation of non-intubated patients prior to and/or during surgical and other procedures.

DEXMEDETOMIDINE KABI dexmedetomidine (as hydrochloride) 200 micrograms/2 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

dexmedetomidine kabi dexmedetomidine (as hydrochloride) 200 micrograms/2 ml concentrated injection vial

fresenius kabi australia pty ltd - dexmedetomidine hydrochloride, quantity: 236 microgram (equivalent: dexmedetomidine, qty 200 microgram) - injection, concentrated - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation,for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine kabi by continuous infusion in these patients should not exceed 24 hours.,procedural sedation,for sedation of non-intubated patients prior to and/or during surgical and other procedures.

DEXMEDETOMIDINE KABI dexmedetomidine (as hydrochloride) 1000 micrograms/10 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

dexmedetomidine kabi dexmedetomidine (as hydrochloride) 1000 micrograms/10 ml concentrated injection vial

fresenius kabi australia pty ltd - dexmedetomidine hydrochloride, quantity: 1180 microgram (equivalent: dexmedetomidine, qty 1000 microgram) - injection, concentrated - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation,for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine kabi by continuous infusion in these patients should not exceed 24 hours.,procedural sedation,for sedation of non-intubated patients prior to and/or during surgical and other procedures.

Natrum Carbonicum Boiron 200K pilules single-dose cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

natrum carbonicum boiron 200k pilules single-dose cont.

boiron - natrum carbonicum 200k 1 % - pillules in single-dose container - 200k - natrum carbonicum 200k 1 %